Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...

Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcersFLORHAM PARK, N.J., April 14, 2025 ...

More New Mexicans will be able to receive treatment for diabetic foot ulcers, thanks to a first-in-the-nation requirement for some health insurance plans to cover the costs. Gov. Michelle Lujan ...

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for ...

As part of the transition to the new administration, CMS is reviewing its coverage policies for skin substitute products.

CMS delays new skin substitute policy to Jan 2026; Kerecis fish-skin grafts stay covered under current rules, backed by ...

Medical products group Convatec shot to the top of the FTSE 100 as it said the sales outlook for InnovaMatrix has improved ...

London stocks had extended gains by midday on Monday as investors mulled the latest twists and turns in Trump’s tariff saga.

April is National Foot Health Awareness Month, a time to think about the importance of foot health in our overall wellbeing, ...

It can be tempting to walk or run without shoes. Some people are even embracing the barefoot lifestyle, going shoeless all the time. What do foot doctors think?

As a result, ConvaTec, the London-based medical products and technologies company said it now expects sales of wound dressing treatment InnovaMatrix of around USD75 million in financial 2025, up from ...

Foot and mouth disease – usually referred to by its acronym FMD – is the most feared livestock disease in the world ...